[go: up one dir, main page]

ZA200906849B - Mineralcorticoid receptor antagonists for the treatment of endomertriosis - Google Patents

Mineralcorticoid receptor antagonists for the treatment of endomertriosis

Info

Publication number
ZA200906849B
ZA200906849B ZA2009/06849A ZA200906849A ZA200906849B ZA 200906849 B ZA200906849 B ZA 200906849B ZA 2009/06849 A ZA2009/06849 A ZA 2009/06849A ZA 200906849 A ZA200906849 A ZA 200906849A ZA 200906849 B ZA200906849 B ZA 200906849B
Authority
ZA
South Africa
Prior art keywords
endomertriosis
treatment
receptor antagonists
mineralcorticoid receptor
mineralcorticoid
Prior art date
Application number
ZA2009/06849A
Inventor
Oliver-Martin Fischer
Ulrike Kaufmann-Reiche
Anja Schmidt
Carsten Moeller
Ulrike Fuhrmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2008/052456 external-priority patent/WO2008107373A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200906849B publication Critical patent/ZA200906849B/en

Links

ZA2009/06849A 2007-03-02 2009-10-01 Mineralcorticoid receptor antagonists for the treatment of endomertriosis ZA200906849B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1020070111105 2007-03-02
PCT/EP2008/052456 WO2008107373A1 (en) 2007-03-02 2008-02-28 Mineralcorticoid receptor antagonists for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
ZA200906849B true ZA200906849B (en) 2015-12-23

Family

ID=60971547

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2009/06849A ZA200906849B (en) 2007-03-02 2009-10-01 Mineralcorticoid receptor antagonists for the treatment of endomertriosis

Country Status (1)

Country Link
ZA (1) ZA200906849B (en)

Similar Documents

Publication Publication Date Title
HUS2200033I1 (en) CGRP receptor antagonists
HK1244694A1 (en) Novel antagonists of the glucagon receptor
IL208895A0 (en) Nmda receptor antagonists for the treatment of neuropsychiatric disorders
AP2739A (en) Azaindazole compounds as CCRI receptor antagonists
HRP20151108T1 (en) Nogo receptor antagonists
IL198650A0 (en) Progesterone receptor antagonists
ZA201105323B (en) Agonists and antagonists of the sip5 receptor,and methods of uses thereof
ZA200909163B (en) Imidazole derivatives as ccr2 receptor antagonists
IL201112A0 (en) Thiazolidine derivatives as orexin receptor antagonists
EP2350024A4 (en) Improved process for the preparation of endothelin receptor antagonists
EP2184278A4 (en) P2x4 receptor antagonist
HK1147674A1 (en) Heterocyclic compounds as crth2 receptor antagonists crth2
IL201165A0 (en) CRIg ANTAGONISTS
IL209264A0 (en) Heteroaromatic monoamides as orexinin receptor antagonists
HK1160642A1 (en) Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists via
HK1163063A1 (en) Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity 5-ht2b -3-
IL198542A0 (en) 2-aminoquinolines as 5-ht(5a)receptor antagonists
IL200380A0 (en) Mineralcorticoid receptor antagonists for the treatment of endometriosis
IL202454A0 (en) Urotensin ii receptor antagonists
ZA200903499B (en) Indoles which act as via receptor antagonists
IL205432A0 (en) Method of identigfying safe nmda receptor antagonists
IL185640A0 (en) Use of 2-anilino-3 ,4-dihydro-quinazolines as 5ht5a receptor antagonists
IL207438A0 (en) 2-aminoquinolines as 5-ht5a receptor antagonists
IL211803A0 (en) Quinazoline derivatives as nk3 receptor antagonists
EP2146576A4 (en) Treatment of down syndrome with benzodiazepine receptor antagonists